M&R Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$141K Hold
908
0.03% 161
2024
Q2
$124K Hold
908
0.03% 164
2024
Q1
$119K Sell
908
-100
-10% -$13K 0.03% 165
2023
Q4
$139K Hold
1,008
0.03% 170
2023
Q3
$123K Hold
1,008
0.03% 171
2023
Q2
$142K Hold
1,008
0.04% 161
2023
Q1
$143K Hold
1,008
0.04% 159
2022
Q4
$158K Hold
1,008
0.04% 152
2022
Q3
$123K Hold
1,008
0.03% 172
2022
Q2
$134K Hold
1,008
0.04% 171
2022
Q1
$137K Buy
1,008
+800
+385% +$112K 0.03% 174
2021
Q4
$35K Hold
208
0.01% 255
2021
Q3
$30K Hold
208
0.01% 265
2021
Q2
$27K Hold
208
0.01% 285
2021
Q1
$26K Hold
208
0.01% 272
2020
Q4
$24K Sell
208
-200
-49% -$24.4K 0.01% 286
2020
Q3
$46K Hold
408
0.01% 245
2020
Q2
$46K Hold
408
0.01% 245
2020
Q1
$32K Hold
408
0.01% 268
2019
Q4
$43K Sell
408
-600
-60% -$62.6K 0.01% 275
2019
Q3
$107K Hold
1,008
0.02% 209
2019
Q2
$102K Buy
1,008
+200
+25% +$19.2K 0.02% 215
2019
Q1
$77K Hold
808
0.02% 235
2018
Q4
$67K Hold
808
0.02% 239
2018
Q3
$87K Hold
808
0.02% 239
2018
Q2
$88K Hold
808
0.02% 238
2018
Q1
$81K Sell
808
-100
-11% -$10.2K 0.02% 245
2017
Q4
$89K Sell
908
-16
-2% -$1.52K 0.02% 240
2017
Q3
$86K Hold
924
0.02% 245
2017
Q2
$98K Hold
924
0.02% 238
2017
Q1
$90K Sell
924
-26
-3% -$2.48K 0.02% 240
2016
Q4
$87K Buy
950
+578
+155% +$49.8K 0.02% 228
2016
Q3
$31K Hold
372
0.01% 321
2016
Q2
$30K Buy
+372
New +$28.3K 0.01% 328

Other funds holding DGX

M&R Capital Management's DGX Position: Q3 2024 in Review

M&R Capital Management held its Quest Diagnostics (DGX) position steady in Q3 2024 at 908 shares worth $141K. The position accounts for 0.03% of the portfolio, ranked #161.

M&R Capital Management first reported a position in DGX in Q2 2016 and has held it in 34 quarters since. The position peaked at $158K in Q4 2022. 847 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

  • M&R Capital Management held 908 shares of Quest Diagnostics worth $141K as of Q3 2024.
  • M&R Capital Management left its Quest Diagnostics share count unchanged in Q3 2024.
  • Quest Diagnostics made up 0.03% of M&R Capital Management's portfolio in Q3 2024, its #161 holding.
  • M&R Capital Management first reported a position in Quest Diagnostics in Q2 2016 and has held it in 34 quarters since.
  • M&R Capital Management's Quest Diagnostics position peaked at $158K in Q4 2022.
  • 847 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.